Bone marker CTX-1 as an indicator of osteoporosis treatment initiation and adherence in clinical practice

被引：0
|
作者：
Senay, Andrea [1 ]
Perreault, Sylvie [1 ]
Delisle, Josee [2 ]
Morin, Suzanne N. [3 ]
Banica, Andreea [2 ]
Laflamme, G. Yves [2 ]
Leduc, Stephane [2 ]
MacThiong, Jean-Marc [2 ]
Ranger, Pierre [2 ]
Rouleau, Dominique [2 ]
Fernandes, Julio C. [2 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
[2] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[3] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
887
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [31] Adherence to statin treatment: an important issue in clinical practice
    Mikhailidis, Dimitri P.
    Katsiki, Niki
    Athyros, Vasilios G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (10) : 1639 - 1640
  • [32] Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women
    Kung, Annie Wai-Chee
    Rachman, Ichramsjah A.
    Adam, John M. F.
    Roeshadi, Djoko
    Torralba, Tito
    Navarra, Sandra
    Gamilla, Zayda
    Canete, Arthur
    de la Rosa, Miles
    Tsai, KehSung
    Lin, Hsiao-Yi
    Soong, Yung Kuei
    Lan, Joung-Liang
    Hsu, Horng-Chaung
    Tu, Shih-Te
    Lin, Ruey-Mo
    Yuktanandana, Pongsak
    Songpatanasilp, Thawee
    Ngarmukos, Srihatach
    Soontrapa, Sugree
    Soontrapa, Suppasin
    Rojanasthien, Sattaya
    Luevitoonvechkij, Sirichai
    Leerapan, Taninnit
    Albert, Adelin
    Vanbelle, Sophie
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2009, 12 (03) : 216 - 224
  • [33] Chi3L1 is a therapeutic target in bone metabolism and a potential clinical marker in patients with osteoporosis
    Park, Kyung-Ran
    Park, Jae-Il
    Lee, Seongsoo
    Yoo, Kyeongwon
    Kweon, Gi-Ryang
    Kwon, Il Keun
    Yun, Hyung-Mun
    Hong, Jin Tae
    PHARMACOLOGICAL RESEARCH, 2022, 184
  • [34] DXA SCAN & FRAX SCORE ARE THE BETTER MONITORING TOOL OF ANTI-OSTEOPOROSIS MEDICATIONS AS COMPARED TO BONE TURNOVER MARKER CTX
    Bajaj, S. K.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S517 - S517
  • [35] Treatment of hypertension and adherence to treatment guidelines in clinical practice: An Italian study
    Malacco, E
    Ferri, C
    Grandi, AM
    Kilama, MO
    Soglian, AG
    Vigna, L
    ADVANCES IN THERAPY, 2005, 22 (02) : 96 - 106
  • [36] Treatment of hypertension and adherence to treatment guidelines in clinical practice: An Italian study
    Ettore Malacco
    Claudio Ferri
    Anna Maria Grandi
    Michael Ochan Kilama
    Andrea Giovanni Soglian
    Luigi Vigna
    Advances in Therapy, 2005, 22 : 96 - 106
  • [37] International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis
    Vasikaran, Samuel
    Cooper, Cyrus
    Eastell, Richard
    Griesmacher, Andrea
    Morris, Howard A.
    Trenti, Tommaso
    Kanis, John A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (08) : 1271 - 1274
  • [38] Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people
    Barnsley, J.
    Buckland, G.
    Chan, P. E.
    Ong, A.
    Ramos, A. S.
    Baxter, M.
    Laskou, F.
    Dennison, E. M.
    Cooper, C.
    Patel, Harnish P.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (04) : 759 - 773
  • [39] The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice
    Walker-Bone, K
    Wood, A
    Hull, R
    Ledingham, JM
    McCrae, FC
    Shaban, R
    Thomas, A
    Mackay, K
    CLINICAL MEDICINE, 2004, 4 (05) : 431 - 436
  • [40] RESULT OF BMD AND BONE TURNOVER MARKERS AFTER ONE YEAR TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH DENOSUMAB (CLINICAL PRACTICE)
    Vanuga, Peter
    Pavai, Dusan
    Pura, Mikulas
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S321 - S321
12345